Stockreport

Takeda Acquisition Of Shire May Bode Well For R&D Staff [Forbes]

TAKEDA PHARMA  (TKPYY) 
NASDAQ:AMEX Investor Relations: takeda.com/investors
PDF In 2014, after a successful 20 year stint at GlaxoSmithKline, Christophe Weber made an eyebrow raising career move by taking over the reins of the Japanese pharmaceu [Read more]